Showing results (331-340 of 1,584) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|December 18, 2024
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow TransplantKristy K Broman, Qingrui Meng, Anna Holmqvist, et al.
JAMA Dermatology|February 5, 2025
Artificial Intelligence-Enabled Wearable Devices and Nocturnal Scratching in Mild Atopic DermatitisAlbert F Yang, Soham Patel, Keum San Chun, et al.
JAMA Dermatology|December 11, 2024
Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous MelanomasSerigne N Lo, Gabrielle J Williams, Anne E Cust, et al.
JAMA Dermatology|December 11, 2024
Melanoma Tumor Mutational Burden and Indoor Tanning ExposureGrace B Hanrahan, Anita Giobbie-Hurder, Blair Allais, et al.
JAMA Dermatology|December 20, 2023
Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical TrialLawrence F Eichenfield, Sanela Tarabar, Seth Forman, et al.
JAMA Dermatology|February 7, 2024
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity, Anthony Moussa, Michaela Bennett, et al.
JAMA Dermatology|January 17, 2024
Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic PrurigoMartin Metz, Claudia Zeidler, Tomasz Hawro, et al.
JAMA Dermatology|January 31, 2024
Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis BullosaAdam J N Raymakers, Aaron S Kesselheim, Arash Mostaghimi, et al.
JAMA Dermatology|January 24, 2024
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 TrialBillal Tedbirt, Maud Maho-Vaillant, Estelle Houivet, et al.
JAMA Dermatology|January 24, 2024
Retrospective Case Series of Cocaine-Associated Plasma Cell Orificial MucositisMyriam Viedma-Martinez, Gonzalo Gallo-Pineda, Miguel Recio-Monescillo, et al.
Pageof 159